Utilizing exosomes for RNAi delivery presents a promising strategy in gene therapy. These natural nanosized vesicles enhance the stability and cellular uptake of RNA interference molecules while reducing immunogenicity. By engineering exosomes to include specific targeting ligands, they can effectively transport therapeutic RNAi to diseased cells, improving the precision of treatments for various conditions, including cancer and genetic disorders.